The Universal Selection Source: Cosmetics Ingredients

Product News

SILAB Focuses on Characterization of Atopic Dermatitis to Develop Purified Natural Active

Published on 2017-09-05. Author : SpecialChem

SILAB softcare department has focused on the in vivo characterization of atopic dermatitis in partnership with Prof. Michel Manfait. These studies have led to the publication of an article in the high impact factor journal, Experimental Dermatology.

SILAB Focuses on Characterization of Atopic Dermatitis to Develop Purified Natural Active
SILAB Focuses on Characterization of Atopic Dermatitis to Develop Purified Natural Active

Atopic Dermatitis Non-Invasively Characterized


The research studies conducted reveal for the first time in vivo, and non-invasively, the molecular signature of atopic skins that reflects changes in the lipid matrix (organization and conformation) and hydration (total and bound water content). This study was carried out using confocal Raman microspectroscopy in vivo in collaboration with the team of Prof. Michel Manfait.

SILAB Biophysics Laboratory Manager, Raoul Vyumvuhore explained:

“The equipment we used has a flexible probe which enables molecular descriptors of the skin to be explored in vivo, whatever area of skin is studied. Highly precise, it also generates masses of data. Expertise of a specific protocol that enables spectra to be sorted and processed is indispensable in order to obtain the necessary quality to exploit them statistically.”

Ambitious Program of Research


Atopic dermatitis is the initial research worked on by SILAB softcare, the new SILAB department dedicated to the care of compromised skin. Started up 5 years ago, the aim of this research program was to decrypt the signature of this pathology by the use of innovative in vitro and in vivo modeling.

Deputy General Manager, Research and Development, SILAB, Brigitte Closs stated:

“After publishing in the British Journal of Dermatology on our SILABSKIN® model mimicking atopic skin in vitro, it is with great satisfaction that we welcome this new evidence of the quality of the studies conducted by the SILAB softcare research teams.”

AD-RESYL®, Natural Active Molecule for Atopic Skin


The results obtained during these in vivo and in vitro modeling enabled to support the development of AD-RESYL®, a purified natural active ingredient capable of preventing the clinical signs of atopic dermatitis and prolonging periods of remission following corticosteroid therapy.

PS: If you liked this News, you might enjoy our Cosmetics Product Newsletter. All the Product News delivered once a week right to your inbox. Sign up here!


Source: SILAB
Be the first to comment on "SILAB Focuses on Characterization of Atopic Dermatitis to Develop Purified Natural Active"

Leave a comment





Your email address and name will not be published submitting a comment or rating implies your acceptance to SpecialChem Terms & Conditions
Covestro
Back to Top